6.14 Randomized, Placebo-Controlled Trial With Open-Label Extension of Intranasal Oxytocin for Autism Spectrum Disorder

Authors :: Terrence C. Bethea
Marina Spanos
Cheryl Alderman
Tara Chandrasekhar
Linmarie Sikich
Jacqueline L. Johnson
Source :: Journal of the American Academy of Child & Adolescent Psychiatry. 60:S162
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pediatrics
medicine.medical_specialty
business.industry
Placebo-controlled study
medicine.disease
Psychiatry and Mental health
Oxytocin
Autism spectrum disorder
Developmental and Educational Psychology
Medicine
Nasal administration
Open label
business
medicine.drug

Full Text Access

Tools